The PVD Channel is pleased to present a multidisciplinary exploration of the value of Intravascular Ultrasound (IVUS) before, during, and after arterial and venous endovascular interventions.
Part I: IVUS-Based Therapies for Chronic Venous Hypertension - The State of Our Knowledge
In Part I of this episode, Paul J. Gagne, MD examines the value of Intravascular Ultrasound, or IVUS, in deep venous interventions. Join Dr. Gagne as he presents and evaluates the latest data, real-world cases, as well as key clinical and prospective studies, to illustrate the advantages of IVUS-guided imaging versus venography. Focusing on patients with chronic venous insufficiency and occlusive disease, Dr. Gagne will discuss appropriate patient selection, compare clinical results, and highlight key areas of differentiation between IVUS and venography, with the goal of helping you improve your patients’ quality of life by providing each individual patient with the optimal method of intervention.
Part II: Medical Management and Follow-Up: Post-Arterial and Venous Endovascular Interventions
In Part II, Laiq Raja, MD and Lorena C. Henderson, APRN discuss their multidisciplinary, patient-centered approach to the optimal management of patients with vascular disease. Dr. Raja and Ms. Henderson detail the clinical studies and personal experiences that have shaped their management style, including the role of pharmacological and non-pharmacological therapies, the importance of proactive follow-up and patient education, and the ways that a coordinated care team can help us in our mission to improve our patients’ quality of life through amputation prevention.
After completing this activity, the participant should be better able to:
- Describe the value of IVUS in arterial and deep venous interventions
- Delineate the differences between IVUS and venography to patients and colleagues
- Describe how to implement stepwise patient management protocols for all stages of disease, incorporating all members of the care team
- Identify cases that can benefit from referral to specialist
The educational design of this activity addresses the needs of Interventional Radiologists, Vascular Surgeons, Vascular Specialists, Nurse Practitioners, Radiologic Technologists, and Vascular Allied Health Professionals involved in the treatment of patients with peripheral vascular disease.
Paul J. Gagne, MD, FACS, RVT — Chairman
Associate Clinical Professor of Surgery
NYU School of Medicine, New York
Private Practice, Darien, CT, USA
Dr. Paul J. Gagne is a board-certified vascular surgeon.
Dr. Gagne attended the NYU School of Medicine, and did his residency in General Surgery at NYU Medical Center. After residency, he served as a vascular surgeon in the US Navy and did a vascular fellowship at the University of Arkansas for Medical Sciences. Dr. Gagne was on faculty at NYU School of Medicine for 8 years before entering private practice in Darien, CT. Dr. Gagne is a Distinguished Member of the Society of Vascular Surgery, a member of the American Venous Forum and serves on the Board of Directors of OEIS.
On March 26, 2013, Dr. Gagne became the first surgeon in the State of Connecticut to implant a drug-eluting stent to reopen a blocked artery in the thigh of a patient with peripheral arterial disease.
Dr. Gagne is also an international leader in the treatment of acute DVT and chronic deep vein occlusive disease in the leg and the long-term complications of DVT.
Dr. Gagne’s research focuses on the deep vein system 1) following acute DVT, and 2) the use of IVUS for evaluating and treating chronic iliofemoral vein outflow obstruction. He was the Global Principal Investigator of the VIDIO trial and has completed or is currently the site Principal Investigator for the VIVO, VIRTUS, ACCESS, VERNACULAR, ABRE, VIVID, VICARES and Varithena trials, focused on all aspects of venous disease. He has also been a sub-investigator for the RANGER, REVEAL and Phoenix trials for the treatment of leg peripheral arterial disease. Dr. Gagne is an invited guest speaker at meetings all over the world to present his work on the treatment of deep vein disease.
Lorena C. Henderson, APRN, MSN, FNP-C
Administrator and Clinical Director
PULSE Amputation Prevention Centers
Clinical Research Coordinator
El Paso Cardiology Associates
El Paso, TX, USA
Lorena C. Henderson is a Family Nurse Practitioner and the Administrator and Clinical Director of the Amputation Prevention and Patient Care Coordination Program at PULSE, a novel multidisciplinary program focused on wound and vascular management and limb preservation.
She also serves as Clinical Research Coordinator for El Paso Cardiology Associates, under the direction of Dr. Laiq Raja, MD.
Lorena earned her Bachelors of Science in Nursing at the University of Texas at El Paso and completed her Masters of Science in Nursing as a Certified Family Nurse Practitioner at the Texas Tech University Health Sciences Center School of Nursing in Lubbock, Texas.
Credentialed at all of the Hospitals of Providence (Sierra, Memorial and Transmountain) and Las Palmas Medical Center in El Paso, Lorena practices under the specialty of cardiology. She has focused specialization in the treatment and management of critical limb ischemia and amputation prevention under the direct supervision of Dr. Laiq Raja, MD, one of the country’s foremost experts in the treatment of critical limb ischemia, who is the director of the Amputation Prevention Program at the Hospitals of Providence as well as PULSE Amputation Prevention Centers.
A published author in Cath Lab Digest and Endovascular Today, Lorena has assisted in the development and initiation of a CLI and Amputation Prevention Treatment Program in collaboration with a local healthcare system as well as being a co-founder of PULSE Amputation Prevention Centers. Early in her career she was also involved in the development of heart failure program initiatives to establish dedicated heart failure clinics. Lorena is a member of the Sigma Theta Tau International Honor Society of Nursing.
Laiq Raja, MD, FACC, FSCAI
El Paso Cardiology Associates
El Paso, TX, USA
Dr. Laiq Raja is an Interventional Cardiologist practicing in El Paso, Texas. Dr. Raja earned his medical degree at the Autonomous University of Cuidad Juárez in Mexico and did his Residency in Internal Medicine at the Texas Tech University Health Sciences Center in El Paso.
Dr. Raja furthered his training, completing fellowships in Cardiovascular Diseases and Interventional Cardiology at the University of Texas Health Sciences Center in San Antonio, and he is an Assistant Professor at Texas Tech University Health Sciences Center in El Paso.
Board-certified by the American Board of Vascular Medicine, the American Board of Interventional Cardiology, the American Board of Cardiology & CV Diseases, the American Board of Internal Medicine, and the Certification Board of Nuclear Cardiology, Dr. Raja has served as principal investigator in numerous clinical research studies and has published in journals including Endovascular Today and Cath Lab Digest.
Since 2018, Dr. Raja has served as Director and President of PULSE Amputation Centers, and he is also the Director of Cardiology and Medical Director of the CLI Program at The Hospitals of Providence (Memorial Campus). To help ensure the best possible care and improved quality of life for all patients, Dr. Raja has trained over 300 physicians nationwide across all vascular specialties.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Educational Awareness Solutions. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Educational Awareness Solutions. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.25 contact hour(s) (which includes 0.2 hour(s) of pharmacology).
American Society of Radiologic Technologists
This activity has been reviewed and approved for 1.25 Category A CE credits by the ASRT.
European Board for Accreditation in Cardiology
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1.0 hour(s) of external CE credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity.
Term of Offering
This activity was released on June 30, 2021 and is valid for one year. Requests for credit must be made no later than July 1, 2022.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the pre-activity questions, view the program in its entirety, and complete the post-activity questions, evaluation form, and credit request.
An Internet-connected web browser is required.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter
|Reported Financial Relationship
Paul J. Gagne, MD, FACS, RVT
Consulting Fees: Philips, Cook Medical, Boston Scientific
|Lorena C. Henderson, APRN, MSN, FNP-C
||Speaker’s Bureau: CSI, Philips, Terumo
|Laiq Raja, MD, FACC, FSCAI
||Advisory Board: Philips, Medtronic, BD
Consulting Fees: Philips, Medtronic, BD, CSI, Terumo
Honoraria: Philips, Medtronic, BD, CSI, Terumo
Speaker’s Bureau: Philips, Medtronic, BD, CSI, Terumo
The planners and managers have the following relevant financial relationships with ineligible companies:
Contracted Research: Vesper, Humacyte, Boston Scientific, PQ Bypass, Merit Medical, Medtronic, Intervene
Speaker’s Bureau: Philips, Cook Medical, Medtronic, Boston Scientific
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Educational Awareness Solutions do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.